MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$119,222K
Net Income
$52,056K
Net Profit Margin
43.66%
EPS
$1.79
Unit: Thousand (K) dollars
Revenue Breakdown
US
Europe
JP
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product revenue, net
119,222
116,357
107,105
97,800
Cost of goods sold
6,437
6,323
6,593
4,263
Research and development
14,518
15,331
14,795
14,585
Selling, general and administrative
39,850
41,014
41,280
37,578
Litigation settlement
-
-
0
0
Total operating expenses
60,805
62,668
62,668
56,426
Income from operations
58,417
53,689
44,437
41,374
Gain from sale of priority review voucher
-
-
0
-
Interest and other income, net
7,662
7,753
6,695
6,593
Income before income taxes
66,079
61,442
51,132
47,967
Income tax expense
11,311
5,510
-268
-31,398
Net income
54,768
55,932
51,400
79,365
Unrealized (gain) loss on available-for-sale securities
-1,213
-1,577
-437
657
Foreign currency translation
-1,499
-1,182
473
-714
Comprehensive income
52,056
53,173
51,436
79,308
Basic EPS
1.85
1.91
1.768
2.74
Diluted EPS
1.79
1.83
1.695
2.66
Basic Average Shares
29,529,000
29,288,000
29,098,000
28,953,000
Diluted Average Shares
30,657,000
30,507,000
30,351,000
29,833,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
US
$91,633K
Europe
$19,283K
JP
$8,306K
Product revenue, net
$119,222K
(24.14%↑ Y/Y)
Income from operations
$58,417K
(48.62%↑ Y/Y)
Interest and other
income, net
$7,662K
(2.60%↑ Y/Y)
Total operating
expenses
$60,805K
(7.17%↑ Y/Y)
Income before income
taxes
$66,079K
(41.27%↑ Y/Y)
Selling, general and
administrative
$39,850K
(13.34%↑ Y/Y)
Research and development
$14,518K
(0.75%↑ Y/Y)
Cost of goods sold
$6,437K
(-10.16%↓ Y/Y)
Net income
$54,768K
(42.87%↑ Y/Y)
Income tax expense
$11,311K
(33.98%↑ Y/Y)
Comprehensive income
$52,056K
(33.14%↑ Y/Y)
Foreign currency
translation
-$1,499K
(-262.05%↓ Y/Y)
Unrealized (gain) loss on
available-for-sale securities
-$1,213K
(-667.72%↓ Y/Y)
Buy us a coffee
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS)